Page 77 - Read Online
P. 77

Page 254               Thomas et al. J Transl Genet Genom 2024;8:249-77  https://dx.doi.org/10.20517/jtgg.2024.15

               Multiplex profiling has revealed a significant enrichment of T and B lymphocytes in the mouse prostate
               gland due to aging. Specifically, a strong correlation was observed between age and enrichment of
                                                                +
                                                                         +
                                                          +
               programmed cell death protein 1 positive (PD-1 ) CD4  and CD8  T cells in the mouse prostate gland.
               PD-1, a cell membrane protein, plays a critical role in inhibiting both T and B-cell immune response, and is
               a marker for T-cell "exhaustion" [47,53,72] . Intriguingly, estrogen modulates immune cells of both myeloid and
               lymphoid lineages in a tissue-context-dependent manner . Given the presence of both myeloid and
                                                                  [73]
               lymphoid cells in prostate gland homeostasis [47,48] , understanding the dynamic changes in the immune
               profile within the prostate gland in the context of testosterone deficiency and estrogenic dominance is
               crucial for comprehending disease development in an aging prostate.


               TUMOR-STROMA INTERACTIONS
               While tissue-emergent/reactive stromal responses in carcinomas are often considered secondary to
               epithelial changes, the limited progression of many epithelial tumors from in situ lesions despite harboring
               genetic abnormalities associated with malignancy raises questions about the driving molecular factors of
               neoplasms [74,75] . Recombinant studies in murine models have provided evidence suggesting that the stromal
               microenvironment is a key determinant in promoting prostate carcinogenesis [76-80] . Moreover, exogenous
               insults directly affecting the stroma have been identified as critical initiators of the carcinogenic process in
               various other solid tumors. For instance, ultraviolet radiation-induced dermal atrophy has been shown to
               precede keratinocyte tumors, while chemicals in cigarette smoke metabolically promote cancer by inducing
               autophagy and premature aging in the host stromal microenvironment in an organ such as the breast [75,81,82] .
               In another example, obesity-induced metabolites derived from gut microbiota induce senescence in hepatic
               stellate cells, which then secrete inflammatory and tumor-promoting factors that facilitate the development
               of hepatocellular carcinoma in mice exposed to chemical carcinogens . Collectively, these instances
                                                                              [83]
               suggest that the tissue stroma may indeed play a primary role in initiating and promoting cancer
               development.

               Thus, the experimental evidence cited above suggests that aging or insult-driven changes of the stroma
               create a permissible emergent/reactive tissue or organ environment (soil) that promotes the growth of
               monoclonal or polyclonal tumors (field cancerization). However, based on this view, sustainable treatment
               or cure for cancer will be difficult to attain as long as the reactive soil persists . Therefore, there is a
                                                                                     [75]
               pressing need to characterize the stromal compartment of solid tumors. One of the main limitations in
               characterizing reactive stroma in prostate cancer is the heterogeneity of cancer-associated fibroblasts
               (CAFs) that make up the TME. Stromal heterogeneity is partially explained by the fact that CAFs can be
               derived from the activation of tissue-resident fibroblasts, mesenchymal stem cells, vimentin-positive
               periacinar cells, circulating bone marrow-derived precursors, vessel-associated pericytes, and endothelial
               cells [10,11] . Spatial transcriptomic analysis of radical prostatectomy-derived tissue, in addition to stromal cell
               lineages identified from single-cell sequencing analyses of mouse prostate stroma, suggests the presence of
               reactive stromal cells with different transcriptional programs and functions within the prostate cancer
               TME  [84,85] . Additionally, the phenotypic plasticity of the activated stromal cells further underscores the
                                               [11]
               dynamic nature of the reactive stroma . Hence, characterizing a moving target such as TME to understand
               tumorigenesis, development, and progression becomes a challenging endeavor.


               STROMAL RESPONSE IN PROSTATE CANCER
               The coordinated host emergent response to tissue injury involves the collective action of cells that make up
               the connective tissue/stroma and the extracellular matrix (ECM) products. The normal reactive stromal
               response to injury is self-limited and regulated spatially and temporally to re-establish tissue integrity and
               reset homeostasis. The mechanisms underlying reactive/emergent stromal response include the release of
   72   73   74   75   76   77   78   79   80   81   82